Bing

VRTX) was upgraded by investment analysts at Vetr from a “hold” rating to a “buy” rating in a report issued on Monday, MarketBeat reports. The firm currently has a $142.57 target price on the pharmaceutical …
Ticker Report · 8/24/2015
Vertex Pharmaceuticals (NASDAQ:VRTX) Director Joshua S. Boger sold 10,400 shares of the business’s stock in a transaction on Wednesday, August 19th. The stock was sold at an average price of $139.93, for a total value of $1,455,272.00. Following …
sleekmoney.com · 8/21/2015
Allergan Plc (AGN): AGN stock is up 3.3% today. Repligen Corp (RGEN): RGEN stock is up 3.2% today. Vertex Pharmaceuticals Inc (VRTX): VRTX stock is up 3.3% today. Some of the biggest losers among healthcare stocks include: Mannkind Corp …
Investor Place · 8/26/2015
More from Bing News
Vetr upgraded shares of Vertex Pharmaceuticals (NASDAQ:VRTX) from a hold rating to a buy rating in a report issued on Monday, Analyst Ratings Net reports. The firm currently has $142.57 price target on the …
Mideast Times · 8/21/2015
One of the S&P 500’s big winners for Thursday August 27 was Vertex Pharmaceuticals Incorporated (VRTX) as the company’s stock climbed 2.8% to $133.75 on volume of 2.01 million shares. The stock opened at $131.49 and saw an intraday low of …
Equities · 8/28/2015
Vertex Pharmaceuticals (NASDAQ:VRTX) Director Joshua S. Boger sold 10,400 shares of the firm’s stock in a transaction on Wednesday, August 12th. The stock was sold at an average price of $135.83, for a total transaction of $1,412,632.00. Following …
wkrb13.com · 8/17/2015
As per the company’s press release, Vertex Pharmaceuticals (VRTX) announced its 2Q15 results on July 29 ... After announcing 2Q15 results, the company’s stock closed at $135.46 on July 30, an increase of 7.
Yahoo Finance · 8/21/2015
Below is a chart of Halliburton Company versus Vertex Pharmaceuticals, Inc. plotting their respective size rank within the S&P 500 over time (HAL plotted in blue; VRTX plotted in green): Below is a three month price history chart comparing the stock ...
Market News Video · 8/28/2015
Short sellers were especially drawn to Biogen Inc (NASDAQ: BIIB), Gilead Sciences, Inc. (NASDAQ: GILD) and Vertex Pharmaceuticals Incorporated (NASDAQ: VRTX) in those two weeks ... Short sellers watched the …
Investopedia · 8/27/2015
Investors in Vertex Pharmaceuticals, Inc. (Symbol: VRTX) saw new options begin trading today, for the October 2nd expiration. At Stock Options Channel, our YieldBoost formula has looked up and down the VRTX options chain for the new October 2nd …
NASDAQ · 8/13/2015

Vertex Pharmaceuticals

Company
Vertex Pharmaceuticals is an American Pharmaceutical company based in Boston, Massachusetts. Vertex was founded in 1989 by Joshu…
Vertex Pharmaceuticals is an American Pharmaceutical company based in Boston, Massachusetts. Vertex was founded in 1989 by Joshua Boger and Kevin J. Kinsella. Vertex was one of the first biotech firms to use an explicit strategy of rational drug design rather than combinatorial chemistry.
Data from: Wikipedia · Freebase